Hospital
Northwest Sahuarita Hospital LLC
Northwest Sahuarita Hospital LLC was paid $8.53M by Medicaid between Nov 2020 and Dec 2024, across 169 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoNORTHWEST SAHUARITA HOSPITAL LLC
SAHUARITA, AZ 85629
SAHUARITA, AZ 85629
33aNPI1851927669assigned 03/13/2020
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.53M
24GClaims241,171
24DCodes billed169
24AFirst – last monthNov 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Arizona
Rank by total paid#43 of 78
Median peer was paid$12.21M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,684 | $55K | |
| 2021 | 19,590 | $747K | |
| 2022 | 62,714 | $2.32M | |
| 2023 | 97,145 | $3.27M | |
| 2024incomplete | 60,038 | $2.14M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 13,878 | 13,089 | $2.22M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 18% | 3,090 | 2,922 | $1.54M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 11,119 | 10,343 | $1.47M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.6% | 3,792 | 3,561 | $816K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6.3% | 1,361 | 1,302 | $540K |
| 70450 | Computed tomography, head or brain; without contrast material | 6.1% | 2,237 | 2,126 | $524K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3.5% | 723 | 700 | $295K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.4% | 3,459 | 3,316 | $287K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.3% | 998 | 972 | $107K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 537 | 510 | $98K |
| G0378 | Hospital observation service, per hour | 1.1% | 1,437 | 883 | $93K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 343 | 328 | $78K |
157 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,084 | $57K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 370 | $38K |
| 93971 | <1% | 294 | $31K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 602 | $29K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 601 | $27K |
| 70498 | <1% | 74 | $26K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,303 | $23K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 6,109 | $22K |
| 72131 | <1% | 164 | $21K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 50 | $20K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 56 | $16K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 77 | $15K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,133 | $14K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,737 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,032 | $9K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 585 | $8K |
| 71250 | <1% | 37 | $8K | |
| 29125 | <1% | 25 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,129 | $7K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 28 | $7K |
| 12001 | <1% | 43 | $5K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 25 | $4K |
| 80053 | Comprehensive metabolic panel | <1% | 11,238 | $4K |
| 73130 | <1% | 373 | $4K | |
| 73610 | <1% | 526 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,319 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,551 | $2K |
| 88342 | <1% | 386 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,982 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,533 | $2K |
| 73630 | <1% | 462 | $2K | |
| 84484 | <1% | 5,252 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $1K |
| 73110 | <1% | 294 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,389 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 326 | $1K |
| 93976 | <1% | 500 | $1K | |
| 93975 | <1% | 114 | $1K | |
| 73030 | <1% | 332 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,448 | $1K |
| 73562 | <1% | 145 | $930.03 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,559 | $893.76 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,047 | $783.90 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,567 | $726.64 |
| 96376 | <1% | 1,085 | $713.80 | |
| 70486 | <1% | 13 | $692.26 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,586 | $665.26 |
| 72100 | <1% | 48 | $613.44 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,670 | $537.45 |
| 70496 | <1% | 85 | $486.18 | |
| 73564 | <1% | 156 | $481.85 | |
| 74018 | <1% | 26 | $439.58 | |
| 82805 | <1% | 59 | $347.72 | |
| 83690 | <1% | 5,610 | $244.71 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 20 | $242.68 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 79 | $242.34 |
| 81001 | <1% | 4,968 | $242.30 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 24 | $200.33 |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,073 | $193.26 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,765 | $180.22 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,480 | $172.50 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 809 | $162.49 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,794 | $154.29 |
| 84703 | <1% | 3,151 | $149.56 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 869 | $142.63 |
| 81025 | <1% | 2,546 | $130.67 | |
| 83880 | <1% | 978 | $111.51 | |
| 83605 | <1% | 1,908 | $109.62 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 429 | $104.97 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 423 | $104.64 |
| 87040 | <1% | 1,528 | $96.24 | |
| 85379 | <1% | 1,347 | $90.42 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 324 | $89.01 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,533 | $83.36 |
| 90715 | <1% | 388 | $80.71 | |
| 73502 | <1% | 13 | $79.34 | |
| 81003 | <1% | 4,160 | $74.49 | |
| 87186 | <1% | 723 | $64.30 | |
| 84702 | <1% | 599 | $61.65 | |
| 73090 | <1% | 40 | $59.97 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,309 | $59.01 |
| 83735 | <1% | 2,664 | $54.18 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,132 | $46.40 |
| 97162 | <1% | 14 | $44.93 | |
| 82962 | <1% | 2,104 | $44.91 | |
| 86140 | <1% | 354 | $32.84 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,604 | $32.58 |
| 85610 | <1% | 1,854 | $31.23 | |
| 87077 | <1% | 723 | $30.73 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 83 | $23.18 |
| 85730 | <1% | 853 | $21.58 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,421 | $20.03 |
| 82248 | <1% | 469 | $18.11 | |
| 85027 | <1% | 687 | $17.56 | |
| 86850 | <1% | 134 | $15.68 | |
| 82077 | <1% | 815 | $15.42 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 33 | $14.71 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 869 | $13.56 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 870 | $13.50 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,850 | $11.47 |
| 86901 | <1% | 418 | $10.09 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 469 | $9.78 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 407 | $8.92 |
| 86900 | <1% | 418 | $7.39 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 453 | $6.57 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 421 | $6.50 |
| 87210 | <1% | 103 | $4.11 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 130 | $1.27 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 141 | $0.90 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,334 | $0.89 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,088 | $0.18 |
| 80143 | 0% | 186 | $0.00 | |
| 80179 | 0% | 195 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 425 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 138 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 585 | $0.00 |
| 87400 | 0% | 203 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 135 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 58 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 430 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 379 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 164 | $0.00 |
| 80061 | Lipid panel | 0% | 27 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 139 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 48 | $0.00 |
| 96367 | 0% | 14 | $0.00 | |
| 84100 | 0% | 47 | $0.00 | |
| 73080 | 0% | 14 | $0.00 | |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 38 | $0.00 |
| 87088 | 0% | 14 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 2,302 | $0.00 |
| 96368 | 0% | 30 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 129 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 306 | $0.00 |
| 87807 | 0% | 205 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 137 | $0.00 |
| 85652 | 0% | 77 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 65 | $0.00 |
| 88304 | 0% | 56 | $0.00 | |
| 82550 | 0% | 237 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 397 | $0.00 |
| 87205 | 0% | 52 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 18 | $0.00 |
| 87070 | 0% | 52 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 36 | $0.00 |
| 85651 | 0% | 41 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 104 | $0.00 |
| 82150 | 0% | 40 | $0.00 | |
| 76801 | 0% | 74 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 25 | $0.00 |
| 94760 | 0% | 23 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 17 | $0.00 |
| J0456 | Injection, azithromycin, 500 mg | 0% | 14 | $0.00 |
| 87147 | 0% | 29 | $0.00 | |
| 80047 | 0% | 19 | $0.00 | |
| 82270 | 0% | 12 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.